MSB 2.17% $1.13 mesoblast limited

Ann: COVID ARDS Trial Topline 60-Day Results, page-1511

  1. 2,261 Posts.
    lightbulb Created with Sketch. 367
    Slightly different to that. NVM only hold the license for Jakafi outside the USA, Incyte own the USA market. So they can sell reme in USA and Jakafi in the rest of the world until reme takes over the rest of the world. win win for them.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.